IMP
Process View
positive regulation of vascular wound healing
Any process that increases the rate, frequency, or extent of blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of vascular wound healing"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | ||
| VEGFA | vascular endothelial growth factor A | 1.000 | Human | |
| NRP1 | neuropilin 1 | 1.000 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.998 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.997 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.990 | Human | |
| PGF | placental growth factor | 0.755 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.668 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.561 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.337 | Human | |
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.292 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.252 | ||
| PDGFC | platelet derived growth factor C | 0.248 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.217 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.214 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.125 | ||
| LDLR | low density lipoprotein receptor | 0.103 | ||
| STC1 | stanniocalcin 1 | 0.098 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.097 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.072 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.065 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.044 | ||
| THBS1 | thrombospondin 1 | 0.038 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.034 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.027 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.026 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.021 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.018 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.016 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.015 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.014 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.014 | ||
| JAG1 | jagged 1 | 0.012 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.012 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.012 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.010 |